Chen, Ke-Neng
Chinese Academy of Medical Sciences & Peking Union Medical College · Peking University · McGill University Health Centre · Samsung Medical Center · Peking University Cancer Hospital · Centre Hospitalier de l’Université de Montréal · National Cancer Center Hospital East · Kanagawa Cancer Center · Stanford Cancer Institute · Université de Montréal · Sungkyunkwan University · Stanford University
2 papers on CoChatORCID 0000-0002-4353-0568
Most cited papers
- Verified
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Wakelee, H., Liberman, M., Kato, T., Tsuboi, M., Lee, S.-H., Gao, S., Chen, K.-N., Dooms, C., Majem, M., Eigendorff, E., et al. (2023) · New England Journal of Medicine
Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 1,180
- Verified
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
Spicer, J., Wang, C., Tanaka, F., Saylors, G. B., Chen, K.-N., Liberman, M., Vokes, E. E., Girard, N., Lu, S., Provencio, M., et al. (2021) · Journal of Clinical Oncology
Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 139
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free